MedPath

Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Diabetic Nephropathy
Interventions
Behavioral: Community-based Integrated CKD Care
Registration Number
NCT02194790
Lead Sponsor
Bhumirajanagarindra Kidney Institute, Thailand
Brief Summary

Chronic kidney disease (CKD) is a major health problem in Thailand. Previous studies have demonstrated that integrated pre-dialysis care may slow the decline in renal function (Nephrol Dial Transplant.2009 Nov;24(11):3426-33). It is interesting to know whether early intervention especially in high risk groups like Diabetic may also improve outcome of these patients in primary health care setting resulting in delay of CKD progression.

Detailed Description

We conducted a 12-month longitudinal study at district A (control) and B (intervention) at Kamphaeng Phet Province, Thailand. Diabetic patients with eGFR ≥ 60 ml/min/1.73m2 were recruited from both districts. Patients in district A (control group) received standard CKD care according to NKF-K/DOQI guidelines1 whereas those in district B (intervention) received, in addition to the standard care, educational activities provided by nutritionist, pharmacist and physiotherapist, and quarterly home visits. Our home visits team consisted of nurse, health care officers and village health volunteers. During each hospital visit of both groups clinical data were assessed. All laboratory parameters were collected every 3 months, and LDL and HbA1C every 6 months. The primary end point was rate of eGFR decline. Secondary outcomes were random urine albumin to creatinine ratio (ACR), blood pressure, waist circumference, HbA1C and LDL .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
238
Inclusion Criteria
  • Diabetic patients with eGFR are equal or more than 60 ml/min/1.73m2 estimated twice at 3 months.
Exclusion Criteria
  • Active glomerular disease, obstructive uropathy, end-stage renal disease, HIV infection, pregnancy, body mass index (BMI) less than 18 or more than 40 kg/m2, being under treatment for malignancy, urine protein-creatinine ratio more than 3.5 g/g creatinine and active urinary sediment (urine red blood cells >3 cells/high power field or urine white blood cells >10 cells/high power field).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
community-based Integrated CKD careCommunity-based Integrated CKD CareStandard CKD care + multidisciplinary team and home visit by community care team
Primary Outcome Measures
NameTimeMethod
The difference of rate of estimated glomerular filtration(eGFR) decline12 months

We compare the difference of rate of eGFR decline from baseline end of the study between the intervention group and control group.

Secondary Outcome Measures
NameTimeMethod
Change from baseline in low density lipoproteins(LDL)12 months
Change from baseline in Random Urine Albumin to Creatinine Ratio12 months
Change from baseline in waist circumference12 months
Change from baseline in Hemoglobin A1C12 months
Change from baseline in systolic blood pressure12 months

Trial Locations

Locations (1)

Bhumirajanagarindra Kidney Institute

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath